News

June 9, 2015June 9, 2015

“Creativity” Is Essential To Treat Difficult Rheumatoid Arthritis Symptoms, According To Specialist

Rheumatologists need to “get creative” while treating rheumatoid arthritis, according to Dr. Daniel Furst, a Carl Pearson Professor of Medicine and director of the Rheumatology Clinical Research Center at the University of California ... Read more

June 8, 2015June 12, 2015

Bristol-Myers Squibb To Present Results On RA Therapy Orencia At EULAR 2015

News, rheumatoid arthritis

Bristol-Myers Squibb will present data from 14 abstracts pertaining to its rheumatoid arthritis therapy Orencia (abatacept) at the European League Against Rheumatism (EULAR) 2015 Annual Meeting. Rheumatoid arthritis is a systemic, chronic ... Read more

June 5, 2015June 5, 2015

Rheumatoid Arthritis Patients Are Still Affected by with Cervical Spine Complications

News, rheumatoid arthritis

In a new study entitled “Cervical spine involvement in rheumatoid arthritis over time: results from a meta-analysis,” the authors performed a retrospective analysis of lesions to the cervical spine in ... Read more

June 3, 2015June 3, 2015

Roche to Present Latest Data on RA Therapy at EULAR 2015

News, rheumatoid arthritis

Roche has been invited to participate in the European League Against Rheumatism Annual Congress (EULAR 2015) and present its latest data regarding treatments for rheumatoid arthritis and other severe autoimmune diseases. The ... Read more

June 1, 2015June 1, 2015

National Survey Finds Rheumatoid Arthritis Severely Impacts Quality of Life

News, rheumatoid arthritis

Health Union conducted a national survey of patients with rheumatoid arthritis (RA) and found that the condition has a severe impact on employment, quality of life and capacity of affordable treatment. ... Read more

May 29, 2015June 8, 2015

SWITCH-RA Study Tests Rituximab Versus TNF Inhibitor in Patients with Rheumatoid Arthritis

News, rheumatoid arthritis

In a recent study titled “Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, ... Read more

May 27, 2015May 27, 2015

Novel Molecular Pathway Could Combat Rheumatoid Arthritis

News, rheumatoid arthritis

Rheumatoid Arthritis is a growing medical concern in the United States, with over 1.5 million adults affected by the disease annually. With RA, the immune system overreacts, attacking the patient’s joints and their ... Read more

May 26, 2015May 26, 2015

Chemical Compound Found to Effectively Reduce Inflammation and Protect Joints in a Rheumatoid Arthritis Rodent Model

News, rheumatoid arthritis

A study led by researchers at Montana State University revealed that a new chemical compound could potentially treat rheumatoid arthritis-related symptoms in an animal model. The study is entitled “Anti-Inflammatory ... Read more

May 22, 2015June 5, 2015

Regeneron and Sanofi Announce Sarilumab Therapy Improves Symptoms in Rheumatoid Arthritis patients

News, rheumatoid arthritis

Regeneron Pharmaceuticals and Sanofi, two leading biopharmaceutical companies focused on researching and developing innovative therapeutic solutions, recently announced that Sarilumab, a human IL-6 receptor antibody, when administered to rheumatoid arthritis (RA) patients ... Read more

May 20, 2015May 20, 2015

Researchers Study Methotrexate Utilization in Rheumatoid Arthritis Patients

News, rheumatoid arthritis

Recently, a group of researchers from Aarhus University in Denmark released study results in which they found that rheumatoid arthritis (RA) patients with high disease activity, older age or a ... Read more